Revolutionary silk-based bioink for 3D printing of ex vivo bone marrow models to advance drug development and personalized medicine

Project Information

SILKink

Grant agreement ID: 101113073

DOI

10.3030/101113073

Project closed

EC signature date 26 April 2023

Start date 1 June 2023

End date 31 May 2026

Funded under

• The European Innovation Council (EIC)

Total cost

€ 2 494 687,50

EU contribution

€ 2 494 687,50

Coordinated by

UNIVERSITA DEGLI STUDI DI PAVIA
Italy

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Websites, patent fillings, videos etc. (1)

Website and Logo

Design of Project Website and Logo

Publications

Other (1)

Bioprinting Soft 3D Models of Hematopoiesis using Natural Silk Fibroin-Based Bioink Efficiently Supports Platelet Differentiation (Adv. Sci. 18/2024)

Author(s): Christian Andrea Di Buduo, Marco Lunghi, Volodymyr Kuzmenko, Pierre-Alexandre Laurent, Giulia Della Rosa, Claudia Del Fante, Damian Edward Dalle Nogare, Florian Jug, Cesare Perotti, Koji Eto, Alessandro Pecci, Itedale Namro Redwan, Alessandra Balduini
Published in: Advanced Science, 2024, ISSN 2198-3844
Publisher: Wiley-VCH GmbH, Weinheim
DOI: 10.1002/advs.202470103

Peer reviewed articles (2)

Bioprinting Soft 3D Models of Hematopoiesis using Natural Silk Fibroin-Based Bioink Efficiently Supports Platelet Differentiation

Author(s): Christian Andrea Di Buduo, Marco Lunghi, Volodymyr Kuzmenko, Pierre-Alexandre Laurent, Giulia Della Rosa, Claudia Del Fante, Damian Edward Dalle Nogare, Florian Jug, Cesare Perotti, Koji Eto, Alessandro Pecci, Itedale Namro Redwan, Alessandra Balduini
Published in: Advanced Science, 2024, ISSN 2198-3844
Publisher: Wiley-VCH GmbH, Weinheim
DOI: 10.1002/advs.202308276

Newly identified roles for PIEZO1 mechanosensor in controlling normal megakaryocyte development and in primary myelofibrosis

Author(s): Abbonante V, Karkempetzaki AI, Leon C, Krishnan A, Huang N, Di Buduo CA, Cattaneo D, Ward CM, Matsuura S, Guinard I, Weber J, De Acutis A, Vozzi G, Iurlo A, Ravid K, Balduini A.
Published in: American Journal of Hematology, 2024, ISSN 1096-8652
Publisher: Wiley Periodicals, LLC.
DOI: 10.1002/ajh.27184

Intellectual Property Rights

Patent (2)

SILK FIBROIN AND RELATED USE FOR 3D BIOPRINTING

Application/Publication number: 22 709805
Date: 2022-02-24
Applicant(s): CELLINK BIOPRINTING AB

SILK FIBROIN AND RELATED USE FOR 3D BIOPRINTING

Application/Publication number: 22 709805
Date: 2022-02-24
Applicant(s): UNIVERSITA DEGLI STUDI DI PAVIA